Scarica l'app Stockscreener
2.44
2.52%
0.06
Annexon Inc Borsa (ANNX) Ultime notizie
Annexon Misses Q2 Earnings, Drives Short-Term Gains Amid Biotech Sector Resilience - AInvest
Annexon Biosciences Faces Financial Risks Amid Global Trade Challenges - MSN
Why Annexon Inc. stock attracts strong analyst attentionMarket Trend Review & Fast Gain Stock Tips - thegnnews.com
Annexon Biosciences Receives Buy Rating and $14 Price Target from Wells Fargo Analyst - AInvest
Annexon Biosciences Reports Q2 2025 Financial Results - TipRanks
Strategies to average down on Annexon Inc.Earnings Trend Report & Daily Profit Maximizing Tips - Newser
Regression Model Predicts Rangebound Movement in Annexon Inc.2025 Geopolitical Influence & Risk Controlled Stock Alerts - sundaytimes.kr
Annexon's Path to Commercialization: Assessing Clinical Milestones and Financial Viability in a High-Risk, High-Reward Biotech Play - AInvest
Annexon Narrows Loss in Fiscal Q2 - The Globe and Mail
Annexon Biosciences Q2 GAAP EPS of -$0.34 Beats Estimates - AInvest
Annexon Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Annexon's Strategic Momentum in 2025: Near-Term Catalysts and Long-Term Value Creation - AInvest
Annexon Reports Q2 2025 Financial Results and Highlights Portfolio Progress, Anticipated Milestones for Tanruprubart, Vonaprument, and ANX1502 - AInvest
Annexon Reports Second Quarter 2025 Financial Results, Portfolio Progress and Key Anticipated Milestones - GlobeNewswire
How Annexon Inc. stock performs during market volatilityAnalyst Downgrade & Safe Capital Growth Plans - Newser
What makes Annexon Inc. stock price move sharplyPortfolio Update Summary & Stepwise Swing Trade Plans - Newser
Momentum divergence signals in Annexon Inc. chartQuarterly Portfolio Report & Consistent Growth Equity Picks - Newser
Can Annexon Inc. lead its sector in growthMarket Risk Summary & Weekly Top Gainers Trade List - 선데이타임즈
Will Annexon Inc. rebound enough to break evenJuly 2025 Reactions & Daily Profit Focused Stock Screening - Newser
Price momentum metrics for Annexon Inc. explainedShare Buyback & Free Verified High Yield Trade Plans - Newser
Is Annexon Inc. stock risky to hold nowCEO Change & Long Hold Capital Preservation Tips - newsyoung.net
Can Annexon Inc. recover in the next quarter2025 Winners & Losers & AI Driven Stock Reports - Newser
Signal strength of Annexon Inc. stock in tech scannersSmart Trend Analysis With Buy Point Cues - Newser
Is Annexon Inc. stock a growth or value playFree Stock Market Watch With Alerts - Newser
Applying sector rotation models to Annexon Inc.Oversold Opportunity Scanner with RSI Data - Newser
How Interest Rate Changes Impact Annexon Inc. Stock PerformancePredictive Screener for Daily Trade Watch - Newser
Will a bounce in Annexon Inc. offer an exitSteady Return Plan Based on Data Analysis - Newser
Is Annexon Inc. stock trending bullishPredictable Big Profit Stocks - kangso.co.kr
Annexon Inc. Building a Base Near SupportWeekly Watchlist of High Movers Released - beatles.ru
Annexon, Inc. (NASDAQ:ANNX) Shares Bought by Zurcher Kantonalbank Zurich Cantonalbank - Defense World
Trend analysis for Annexon Inc. this weekDay Trading Plan with Entry Risk Management - Newser
How to forecast Annexon Inc. trends using time seriesSafe Entry Screening with Data Backed Analysis - Newser
Combining price and volume data for Annexon Inc.Free ROI Driven Equity Selection With Safety - Newser
Momentum Screeners Rank Annexon Inc. in Top 5 TodaySwing Trading Entry Signals Suggest Opportunity Zone - metal.it
What is Annexon Inc. s 5 year growth outlookElite Portfolio Components - mustnews.co.kr
Annexon ANNX 2025Q2 Earnings Preview Downside Expected Amid Weak Eurozone Economic Sentiment - AInvest
Will Annexon Inc. stock go up soonIntraday Price Forecast Using Volume Models - Newser
Annexon, Inc. Announces vonaprument's Selection for EMA's PDC Pilot Program, Paving the Way for Potential Dry AMD Treatment Approval - Quiver Quantitative
Annexon Selected by EMA to Participate in Product Development Coordinator Pilot for Vonaprument (ANX007) for Dry Age-Related Macular Degeneration with Geographic Atrophy - The Manila Times
Breakthrough Eye Drug Among 20 Selected for EMA Fast Track: Could Be First Dry AMD Treatment in Europe - Stock Titan
Annexon, Inc. (NASDAQ:ANNX) Shares Sold by TD Asset Management Inc - Defense World
What makes Annexon Inc. stock attractive to long term investorsHigh Growth Low Risk Stock Selection Gets Analyst Nod - beatles.ru
What is the dividend policy of Annexon Inc. stockDiscover the fastest growing stocks today - Jammu Links News
Why is Annexon Inc. stock attracting strong analyst attentionInvest smarter with expert stock picks - Jammu Links News
Should I hold or sell Annexon Inc. stock in 2025Identify undervalued stocks ready to soar - Jammu Links News
Does Annexon Inc. stock perform well during market downturnsOver 200% growth - Jammu Links News
Is Annexon Inc. a growth stock or a value stockCapitalize on momentum-driven investment opportunities - Jammu Links News
What is Annexon Inc. company’s growth strategyAccelerated profit realization - Jammu Links News
When is Annexon Inc. stock expected to show significant growthExtraordinary earning power - Jammu Links News
What markets is CYCC expanding into Is Annexon Inc. stock a good long term investment option - Jammu Links News
Annexon Inc. Stock Analysis and ForecastSuperior capital gains - Jammu Links News
What are analysts’ price targets for Annexon Inc. in the next 12 monthsBreakthrough wealth creation - Jammu Links News
0.41%
0.88%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):